Peculiarities of Cell Seeding on Electroformed Polycaprolactone Scaffolds Modified with Surface-Active Agents Triton X-100 and Polyvinylpyrrolidone.


Journal

Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 17 02 2020
pubmed: 11 9 2020
medline: 10 7 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

We compared the capability of human fibroblasts to populate porous polycaprolactone (PCL) scaffolds modified during fabrication with surface-active agents Triton Х-100 (type 1 scaffold) and polyvinylpyrrolidone (type 2 scaffold). The mean fiber diameter in both scaffolds was almost the same: 3.90±2.19 and 2.46±2.15 μ, respectively. Type 1 scaffold had higher surface density and hydrophilicity, when type 2 scaffold was 1.6 times thicker. The cells were seeded on the scaffolds by the dynamic seeding technique and then cultured in Petri dishes with nutrient medium in a humid atmosphere. During 3-day culturing, no cell release from the matrix was noted. DAPI staining proved the presence of cells in both scaffolds. However, in type 1 scaffold the cells populated the whole thickness, while in type 2 scaffold, the cells were present only in the superficial layer. These findings suggest that PCL scaffolds modified with Triton Х-100 or polyvinylpyrrolidone are not cytotoxic, but the structure of the scaffold treated with Triton Х-100 is more favorable for population with cells.

Identifiants

pubmed: 32910398
doi: 10.1007/s10517-020-04936-0
pii: 10.1007/s10517-020-04936-0
doi:

Substances chimiques

Biocompatible Materials 0
Polyesters 0
Surface-Active Agents 0
polycaprolactone 24980-41-4
Octoxynol 9002-93-1
Povidone FZ989GH94E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-604

Auteurs

S A Afanasiev (SA)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. tursky@cardio-tomsk.ru.

E F Muslimova (EF)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

Yu A Nashchekina (YA)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

P O Nikonov (PO)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

Yu V Rogovskaya (YV)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

T Kh Tenchurin (TK)

National Research Center "Kurchatov Institute", Moscow, Russia.

E V Nesterenko (EV)

National Research Center "Kurchatov Institute", Moscow, Russia.

E V Grakova (EV)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

K V Kopeva (KV)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

S D Akhmedov (SD)

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH